Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Allergan divulges CCR-6 antagonists

March 6, 2019

Mirikizumab maintains response and safety in phase II study in patients with psoriasis

March 6, 2019

Processa Pharmaceuticals reports preliminary safety data for PCS-499

March 6, 2019

Phase III data presented for trifarotene in patients with facial and truncal acne

March 6, 2019

New phase Ib trial explores use of AVID-200 in diffuse cutaneous systemic sclerosis

March 5, 2019

BirchBioMed initiates proof-of-concept study with FS-2 to reduce keloid scars

March 4, 2019

Funding to support exploration of TXA-127 for epidermolysis bullosa

March 4, 2019

Foamix presents positive safety and efficacy data from phase III study of FMX-103

Feb. 28, 2019

FunPep gains Australian clearance for phase I/IIa study of FPP-003

Feb. 27, 2019

Salt plays role in dermatitis risk

Feb. 26, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...